Welcome to our dedicated page for Trulieve Cannabis SEC filings (Ticker: TCNNF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Trulieve Cannabis Corp. (TCNNF) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including current reports on Form 8-K and periodic financial statements. As a British Columbia–incorporated issuer with operations in the United States, Trulieve files with the Securities and Exchange Commission, offering detailed insight into its financial condition, capital structure, and material events.
Trulieve’s recent Form 8-K filings illustrate how the company uses SEC reports to communicate significant developments. For example, the company has filed 8-Ks describing commitments for, and the issuance of, 10.5% senior secured notes due 2030, including key terms such as interest rate, maturity, security (a pledge of shares of a restricted subsidiary), optional redemption provisions, and covenants that limit additional indebtedness, restricted payments, asset sales, and affiliate transactions. These filings also explain that net proceeds are intended for capital expenditures and general corporate purposes.
Other 8-Ks cover topics such as the redemption and planned delisting of 8.0% senior secured notes due 2026, and the release of quarterly financial results. In these documents, Trulieve reports revenue, gross profit, net loss, cash flow from operations, and non-GAAP measures, along with condensed balance sheets and cash flow statements. Investors can use these filings to analyze trends in retail revenue, operating expenses, leverage, and liquidity.
Through Stock Titan, users can view Trulieve’s 10-Q and 10-K filings when available, which provide more comprehensive discussions of risk factors, tax matters (including Section 280E and uncertain tax positions), and segment performance. The platform’s AI-powered summaries help explain complex sections, such as debt indentures, covenant packages, and non-GAAP reconciliations, so readers can quickly grasp what changes in each filing may mean for Trulieve’s operations and capital structure. Real-time updates ensure that new Forms 4, 8-K, 10-Q, and 10-K are surfaced as they are posted to EDGAR.
Trulieve Cannabis Corp. has raised an additional
The notes bear interest at 10.5% per year, paid semi-annually starting
Trulieve may redeem the notes at specified premiums beginning in
Trulieve Cannabis Corp. executive Christine Ann Hersey, Chief Corporate Affairs & Strategy, has filed an initial statement of beneficial ownership. She directly holds 85,173 subordinate voting shares, which include several grants of restricted stock units that vest over multiple years.
Hersey also holds multiple stock options giving her the right to buy Trulieve subordinate voting shares at exercise prices ranging from $3.99 to $47.23, with expiration dates between 2029 and 2032. These options generally vest in annual installments, with portions already exercisable and the remainder scheduled to vest through December 2027.
Trulieve Cannabis Corp. reported that Marex Securities Products Inc. and Marex Group plc beneficially own 9,750,000 subordinate voting shares, representing 5.81% of this class as of the reported event.
The Marex entities have sole power to vote and dispose of these 9,750,000 shares, with no shared voting or dispositive power disclosed. They certify that the shares were not acquired and are not held for the purpose or effect of changing or influencing control of Trulieve Cannabis Corp.
Trulieve Cannabis Corp. issued $140 million of 10.5% senior secured notes maturing on December 17, 2030 in a private placement. The notes were priced at 100% of face value and pay interest semi-annually each June 17 and December 17, starting June 17, 2026.
The notes are guaranteed by restricted subsidiaries, currently including Trulieve, Inc., and are secured by a pledge of shares of Trulieve, Inc. Trulieve may redeem the notes at specified premiums starting December 17, 2027, and holders can require repurchase at 101% of principal plus accrued interest if there is a change of control.
The indenture includes covenants that limit additional indebtedness, liens, dividends, asset sales, certain investments, affiliate transactions and transfers of material permits. Trulieve plans to use the $140 million of gross proceeds for capital expenditures and other general corporate purposes.
Trulieve Cannabis Corp. announced it has received commitments for a private placement of
The Notes may be redeemed in whole or in part on or after the date that is two years following the issue date, at redemption prices to be set in a supplemental indenture. Trulieve intends to use the net proceeds from this Offering for capital expenditures and other general corporate purposes. The Notes are being sold in a private offering to qualified institutional buyers, accredited investors, and certain non‑U.S. persons under exemptions from U.S. securities registration requirements.
Trulieve Cannabis Corp.'s Chief Sales Officer reported an automatic share withholding related to equity compensation. On December 1, 2025, 16,744 subordinate voting shares were disposed of at $5.39 per share under transaction code “F,” which indicates shares withheld to cover tax obligations on vesting restricted stock units. After this tax-related transaction, the officer directly beneficially owned 174,709 subordinate voting shares of Trulieve Cannabis Corp. This filing reflects routine administration of previously granted RSUs rather than an open‑market trade.
Trulieve Cannabis Corp. Chief Legal Officer reports tax-related share withholding
Trulieve Cannabis Corp. officer Eric Powers, the company’s Chief Legal Officer, reported a routine transaction involving the company’s subordinate voting shares. On December 1, 2025, 18,206 subordinate voting shares were withheld at a price of $5.39 per share to cover tax liabilities arising from the vesting of previously granted restricted stock units. This did not represent an open-market sale.
After this withholding, Powers beneficially owns 186,717 subordinate voting shares directly and an additional 1,000 subordinate voting shares indirectly through his spouse. The filing is made on Form 4 and reflects equity compensation and related tax settlement rather than a discretionary trade.
Trulieve Cannabis Corp. reported an insider equity transaction by its Chief Technology Officer. On December 1, 2025, 18,041 subordinate voting shares were withheld at a price of $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this tax withholding, the reporting person beneficially owns 180,660 subordinate voting shares directly and an additional 7,000 shares indirectly through a spouse. This filing reflects a routine administrative adjustment related to equity compensation rather than an open-market trade.
Trulieve Cannabis Corp. reported an insider equity transaction by its Chief Production Officer on a Form 4. On December 1, 2025, 18,359 subordinate voting shares were withheld at a price of $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this tax‑withholding event, the reporting person beneficially owned 200,182 subordinate voting shares directly. This filing reflects routine equity compensation and related tax settlement rather than an open-market purchase or sale.
Trulieve Cannabis Corp. Chairman and CEO Kim Rivers reported a routine insider transaction related to equity compensation. On December 1, 2025, 63,237 Subordinate Voting Shares were withheld at $5.39 per share to cover tax obligations arising from the vesting of previously granted restricted stock units. After this withholding, she beneficially owned 2,137,170 Subordinate Voting Shares directly.
The filing also notes additional holdings, including Multiple Voting Shares and vested stock options. As of this report, Rivers is listed as a Director, 10% owner, Chairman and CEO, and the filing is made by a single reporting person.
FAQ
What is the current stock price of Trulieve Cannabis (TCNNF)?
What is the market cap of Trulieve Cannabis (TCNNF)?
